2017
DOI: 10.1038/s41598-017-14265-4
|View full text |Cite
|
Sign up to set email alerts
|

Telmisartan Activates PPARδ to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in Mice

Abstract: Major depression is a common mental disorder that has been established to be associated with a decrease in serotonin and/or serotonin transporters in the brain. Peroxisome proliferator-activated receptor δ (PPARδ) has been introduced as a potential target for depression treatment. Telmisartan was recently shown to activate PPARδ expression; therefore, the effectiveness of telmisartan in treating depression was investigated. In unpredictable chronic mild stress (UCMS) model, treatment with telmisartan for five … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 56 publications
1
10
0
Order By: Relevance
“…For the tests of OFT and SPT, we found a trend for telmisartan to improve the decreased locomotor activity and sucrose preference, although these were not significant. A previous study showed that the treatment with telmisartan of 1 mg/kg for five weeks could notably improve the depressive symptoms in the stress mouse model [ 33 ]. Hence, the not significant effect may be due to the short treatment time and a relatively small dose for rats.…”
Section: Discussionmentioning
confidence: 99%
“…For the tests of OFT and SPT, we found a trend for telmisartan to improve the decreased locomotor activity and sucrose preference, although these were not significant. A previous study showed that the treatment with telmisartan of 1 mg/kg for five weeks could notably improve the depressive symptoms in the stress mouse model [ 33 ]. Hence, the not significant effect may be due to the short treatment time and a relatively small dose for rats.…”
Section: Discussionmentioning
confidence: 99%
“…Open-filed test (Li et al, 2017, Kuang et al, 2016): The device is a vertical square open box, 40 cm high, 80 cm long and 80 cm wide. The surrounding wall and the bottom surface are black, and the bottom surface is composed of 25 pieces of equal area, divided by white lines.…”
Section: Experimental Methodsmentioning
confidence: 99%
“…10 Another study showed that telmisartan has an effect on improving the PPAR delta receptors and also increasing the hippocampal activity of PPAR thereby improving depression. 11 A study by Wang et al mentioned telmisartan as a very promising neuroprotective compound and substantiates the therapeutic use of this drug in neurodegenerative diseases and traumatic brain disorders where glutamate neurotoxicity plays a significant role. 12 Saavedra et al mentions that the use of sartans may be beneficial for the treatment of many brain disorders.…”
Section: Discussionmentioning
confidence: 94%